NCT06880302 Male Infertility and Assisted Reproductive Technologies Research Biobank
| NCT ID | NCT06880302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Reproductive Medicine Associates of New Jersey |
| Condition | Male Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-03-04 |
| Primary Completion | 2032-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-03-04 with a primary completion date of 2032-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).
Eligibility Criteria
Inclusion Criteria: * Males providing testicular tissue, sperm, semen samples, discarded sperm preps for IUI/IVF/ICSI or the sperm recipient for those utilizing donor sperm, for cryopreservation at the respective site(s) for either clinical use or preservation Exclusion Criteria: * Samples that are quarantined or in isolation dewars for infectious diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06880302 clinical trial?
This trial is open to male participants only, studying Male Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06880302 currently recruiting?
Yes, NCT06880302 is actively recruiting participants. Contact the research team at clinicalresearchteam@ivirma.com for enrollment information.
Where is the NCT06880302 trial being conducted?
This trial is being conducted at Basking Ridge, United States.
Who is sponsoring the NCT06880302 clinical trial?
NCT06880302 is sponsored by Reproductive Medicine Associates of New Jersey. The trial plans to enroll 1,000 participants.